| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;94:922-927.)
© 1996 American Heart Association, Inc.
Articles |
Cohort Study of Cytomegalovirus Infection as a Risk Factor for Carotid Intimal-Medial Thickening, a Measure of Subclinical Atherosclerosis
the Department of Epidemiology, The Johns Hopkins University School of Hygiene and Public Health (F.J.N., H.F., G.W.C., M.S.), Baltimore, Md; Division of Molecular Virology, Baylor College of Medicine (E.A., J.L.M.), Houston, Tex; and National Heart, Lung, and Blood Institute, National Institutes of Health (P.S.), Bethesda, Md.
Background Animal studies as well as clinical and cross-sectional epidemiological studies in humans have suggested a possible role of cytomegalovirus (CMV) and other herpesvirus infections in the development of cardiovascular disease.
Methods and Results The present report is based on a case-control study nested within a historical cohort. The case group comprised 150 individuals with elevated carotid intimal-medial thickness (IMT) measured by B-mode ultrasound at the first two examinations of the Atherosclerosis Risk in Communities (ARIC) Study (1987 through 1992). The control group comprised 150 age- and sex-matched individuals with low IMT. Antibody titers for CMV and herpesvirus 1 and 2 were determined in sera obtained in 1974 as part of a community-wide survey conducted in Washington County, Maryland. Case subjects had higher mean CMV antibody titers in 1974 sera than control subjects, although the difference was not statistically significant when adjusted for other cardiovascular risk factors. There was evidence of a graded relation between the odds of intimal-medial thickening and the levels of CMV antibodies that remained significant after adjustment for the main cardiovascular risk factors (P=.013). The adjusted odds ratio for a high CMV antibody titer (a positive/negative value 
20) compared with a positive/negative value <4 was 5.3 (95% confidence interval, 1.5 to 18.0).
Conclusions The results from this first population-based cohort study of CMV infection and carotid IMT are compatible with the hypothesis of a causal role of CMV in atherosclerosis.
Key Words: atherosclerosis • viruses • risk factors • carotid arteries • follow-up studies
This article has been cited by other articles:
 |
|
 |
|
  F J. Nieto Commentary: Understanding the pathophysiology of poverty Int. J. Epidemiol., June 1, 2009; 38(3): 787 - 790. [Full Text] [PDF]
|
|
|
|
 |
|
 Honors and Awards * Bibliography of Peer-Reviewed Journal Articles Am. J. Epidemiol., October 1, 2008; 168(7): 845 - 854. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qiu, K. Straat, A. Rahbar, M. Wan, C. Soderberg-Naucler, and J. Z. Haeggstrom Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells J. Exp. Med., January 21, 2008; 205(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Steptoe, A Shamaei-Tousi, A Gylfe, B Henderson, S Bergstrom, and M Marmot Socioeconomic status, pathogen burden and cardiovascular disease risk Heart, December 1, 2007; 93(12): 1567 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K.-H. Chow, B. Razani, and G. Cheng Innate immune system regulation of nuclear hormone receptors in metabolic diseases J. Leukoc. Biol., August 1, 2007; 82(2): 187 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Shen, L. Zhang, B. Utama, J. Wang, Y. Gan, X. Wang, J. Wang, L. Chen, G. M. Vercellotti, J. S. Coselli, et al. Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10) Cardiovasc Res, February 1, 2006; 69(2): 502 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Charakida, A. E. Donald, H. Green, C. Storry, M. Clapson, M. Caslake, D. T. Dunn, J. P. Halcox, D. M. Gibb, N. J. Klein, et al. Early Structural and Functional Changes of the Vasculature in HIV-Infected Children: Impact of Disease and Antiretroviral Therapy Circulation, July 5, 2005; 112(1): 103 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Reinhardt, T. Mertens, U. Mayr-Beyrle, H. Frank, A. Luske, K. Schierling, and J. Waltenberger HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF {beta}-receptor Cardiovasc Res, July 1, 2005; 67(1): 151 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Charakida, A. E. Donald, M. Terese, S. Leary, J. P. Halcox, A. Ness, G. D. Smith, J. Golding, P. Friberg, N. J. Klein, et al. Endothelial Dysfunction in Childhood Infection Circulation, April 5, 2005; 111(13): 1660 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. M. van Leeuwen, E. B. M. Remmerswaal, M. T. M. Vossen, A. T. Rowshani, P. M. E. Wertheim-van Dillen, R. A. W. van Lier, and I. J. M. ten Berge Emergence of a CD4+CD28- Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection J. Immunol., August 1, 2004; 173(3): 1834 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Smith, G. L. Bentz, P. M. Smith, E. R. Bivins, and A. D. Yurochko HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner J. Leukoc. Biol., July 1, 2004; 76(1): 65 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.H. Shen, B. Utama, J. Wang, M. Raveendran, D. Senthil, W.J. Waldman, J.D. Belcher, G. Vercellotti, D. Martin, B.M. Mitchelle, et al. Human Cytomegalovirus Causes Endothelial Injury Through the Ataxia Telangiectasia Mutant and p53 DNA Damage Signaling Pathways Circ. Res., May 28, 2004; 94(10): 1310 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Smith, G. L. Bentz, J. S. Alexander, and A. D. Yurochko Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence J. Virol., May 1, 2004; 78(9): 4444 - 4453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Nerheim, J. L. Meier, M. A. Vasef, W.-G. Li, L. Hu, J. B. Rice, D. Gavrila, W. E. Richenbacher, and N. L. Weintraub Enhanced Cytomegalovirus Infection in Atherosclerotic Human Blood Vessels Am. J. Pathol., February 1, 2004; 164(2): 589 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hirabayashi, T. Ishii, T. Kodera, H. Fujii, Y. Munakata, and T. Sasaki Acute Cytomegalovirus Infection and Transient Carotid Intimal-Medial Thickening in a Young, Otherwise Healthy Woman J. Clin. Microbiol., August 1, 2003; 41(8): 3978 - 3980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Basi, K. F. Ross, J. S. Hodges, and M. C. Herzberg The Modulation of Tissue Factor by Endothelial Cells during Heat Shock J. Biol. Chem., March 21, 2003; 278(13): 11065 - 11071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Smieja, J. Gnarpe, E. Lonn, H. Gnarpe, G. Olsson, Q. Yi, V. Dzavik, M. McQueen, S. Yusuf, and for the Heart Outcomes Prevention Evaluation (HOPE Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study Circulation, January 21, 2003; 107(2): 251 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, J. Zhu, J. P.J. Halcox, M. A. Waclawiw, S. E. Epstein, and A. A. Quyyumi Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction Circulation, July 9, 2002; 106(2): 184 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Buerger, J. Reefschlaeger, W. Bender, P. Eckenberg, A. Popp, O. Weber, S. Graeper, H.-D. Klenk, H. Ruebsamen-Waigmann, and S. Hallenberger A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products J. Virol., October 1, 2001; 75(19): 9077 - 9086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blankenberg, H. J. Rupprecht, C. Bickel, C. Espinola-Klein, G. Rippin, G. Hafner, M. Ossendorf, K. Steinhagen, and J. Meyer Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease Circulation, June 19, 2001; 103(24): 2915 - 2921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Ameriso, E. A. Fridman, R. C. Leiguarda, G. E. Sevlever, and J. D. Spence Detection of Helicobacter pylori in Human Carotid Atherosclerotic Plaques Editorial Comment Stroke, February 1, 2001; 32(2): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhu, F. J. Nieto, B. D. Horne, J. L. Anderson, J. B. Muhlestein, and S. E. Epstein Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death Circulation, January 2, 2001; 103(1): 45 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Speir, Z.-X. Yu, K. Takeda, V. J. Ferrans, and R. O. Cannon III Antioxidant Effect of Estrogen on Cytomegalovirus-Induced Gene Expression in Coronary Artery Smooth Muscle Cells Circulation, December 12, 2000; 102(24): 2990 - 2996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Woods, D.J. Brull, S.E. Humphries, and H.E. Montgomery Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6 Eur. Heart J., October 1, 2000; 21(19): 1574 - 1583. [PDF]
|
|
|
|
 |
|
 S A Morre, W Stooker, W K Lagrand, A J C van den Brule, and H W M Niessen Microorganisms in the aetiology of atherosclerosis J. Clin. Pathol., September 1, 2000; 53(9): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Espinola-Klein, H.-J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, G. Rippin, G. Hafner, U. Pfeifer, and J. Meyer Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? Stroke, September 1, 2000; 31(9): 2127 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A.-R. Higazi, T. Nassar, T. Ganz, D. J. Rader, R. Udassin, K. Bdeir, E. Hiss, B. S. Sachais, K. J. Williams, E. Leitersdorf, et al. The alpha -defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis Blood, August 15, 2000; 96(4): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Sorlie, F. J. Nieto, E. Adam, A. R. Folsom, E. Shahar, and M. Massing A Prospective Study of Cytomegalovirus, Herpes Simplex Virus 1, and Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study Arch Intern Med, July 10, 2000; 160(13): 2027 - 2032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Epstein, J. Zhu, M. S. Burnett, Y. F. Zhou, G. Vercellotti, and D. Hajjar Infection and Atherosclerosis : Potential Roles of Pathogen Burden and Molecular Mimicry Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1417 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wildman, J. G Ayres, P.-Y. Lovey, and A. Morabia Long term vascular complications of Coxiella burnetii infection BMJ, January 1, 2000; 320(7226): 58a - 58. [Full Text]
|
|
|
|
|
|
F. J. Nieto, M. Szklo, P. D. Sorlie, P. M. Ridker, C. H. Hennekens, M. J. Stampfer, and F. Wang Cytomegalovirus Infection and Coronary Heart Disease • Response Circulation, December 21, 1999; 100 (25): e139 - e139. [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Wiedermann, S. Kiechl, S. Dunzendorfer, P. Schratzberger, G. Egger, F. Oberhollenzer, and J. Willeit Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the bruneck study J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1975 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhu, A. A. Quyyumi, J. E. Norman, G. Csako, and S. E. Epstein Cytomegalovirus in the pathogenesis of atherosclerosis: The role of inflammation as reflected by elevated C-reactive protein levels J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1738 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Epstein and J. Zhu Lack of Association of Infectious Agents With Risk of Future Myocardial Infarction and Stroke : Definitive Evidence Disproving the Infection/Coronary Artery Disease Hypothesis? Circulation, September 28, 1999; 100(13): 1366 - 1368. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Hak, C. D. A. Stehouwer, M. L. Bots, K. H. Polderman, C. G. Schalkwijk, I. C. D. Westendorp, A. Hofman, and J. C. M. Witteman Associations of C-Reactive Protein With Measures of Obesity, Insulin Resistance, and Subclinical Atherosclerosis in Healthy, Middle-Aged Women Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1986 - 1991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Lovey, A. Morabia, D Bleed, O Péter, G Dupuis, and J Petite Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study BMJ, July 31, 1999; 319(7205): 284 - 286. [Abstract] [Full Text]
|
|
|
|
|
|
J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction : A Potential Role for Cytokines Originating From Adipose Tissue? Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 972 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D P Strachan, D Carrington, M A Mendall, B K Butland, P M Sweetnam, and P C Elwood Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study Heart, March 1, 1999; 81(3): 248 - 251. [Abstract] [Full Text]
|
|
|
|
|
|
B. Fagerberg, J. Gnarpe, H. Gnarpe, S. Agewall, and J. Wikstrand Chlamydia pneumoniae but Not Cytomegalovirus Antibodies Are Associated With Future Risk of Stroke and Cardiovascular Disease : A Prospective Study in Middle-Aged to Elderly Men With Treated Hypertension Stroke, February 1, 1999; 30(2): 299 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tiran, R. A. Tio, E. Oostenveld, M. C. Harmsen, B. Tiran, P. Den Heijer, S. H. J. Monnink, M. M. Wilders-Truschnig, and T. H. The Humoral Immune Response to Human Cytomegalovirus in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty Clin. Vaccine Immunol., January 1, 1999; 6(1): 45 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Rohde, R. T. Lee, J. Rivero, M. Jamacochian, L. H. Arroyo, W. Briggs, N. Rifai, P. Libby, M. A. Creager, and P. M. Ridker Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Presti, J. L. Pollock, A. J. Dal Canto, A. K. O'Guin, and H. W. Virgin IV Interferon {gamma} Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels J. Exp. Med., August 3, 1998; 188(3): 577 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Krosky, M. R. Underwood, S. R. Turk, K. W.-H. Feng, R. K. Jain, R. G. Ptak, A. C. Westerman, K. K. Biron, L. B. Townsend, and J. C. Drach Resistance of Human Cytomegalovirus to Benzimidazole Ribonucleosides Maps to Two Open Reading Frames: UL89 and UL56 J. Virol., June 1, 1998; 72(6): 4721 - 4728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ridker Inflammation, Infection, and Cardiovascular Risk : How Good Is the Clinical Evidence? Circulation, May 5, 1998; 97(17): 1671 - 1674. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Sutherland, C. M. Raynor, H. Leenknegt, J. F. Wright, and E. L. G. Pryzdial Coagulation initiated on herpesviruses PNAS, December 9, 1997; 94(25): 13510 - 13514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Libby, D. Egan, and S. Skarlatos Roles of Infectious Agents in Atherosclerosis and Restenosis: An Assessment of the Evidence and Need for Future Research Circulation, December 2, 1997; 96(11): 4095 - 4103. [Full Text]
|
|
|
|
|
|
F. J. Nieto, P. Sorlie, G. W. Comstock, K. Wu, E. Adam, J. L. Melnick, and M. Szklo Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link? Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1780 - 1785. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. Grau, F. Buggle, C. Ziegler, W. Schwarz, J. Meuser, A.-J. Tasman, A. Buhler, C. Med, C. Benesch, H. Becher, et al. Association Between Acute Cerebrovascular Ischemia and Chronic and Recurrent Infection Stroke, September 1, 1997; 28(9): 1724 - 1729. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Buja Does Atherosclerosis Have an Infectious Etiology? Circulation, September 1, 1996; 94(5): 872 - 873. [Full Text]
|
|